Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis
Hosein Nakhaee, Moein Zangiabadian, R. Bayati, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0267423-e0267423
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Treatment of 95 post-Covid patients with SSRIs
Carla P. Rus, Bert E. K. de Vries, Ingmar E. J. de Vries, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Dhammika Leshan Wannigama, Cameron Hurst, Phatthranit Phattharapornjaroen, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102517-102517
Open Access | Times Cited: 9
Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study
Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, María Piñeiro‐Lamas, et al.
European Neuropsychopharmacology (2023) Vol. 71, pp. 96-108
Open Access | Times Cited: 13
The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study
Katharina Schultebraucks, Wivine Blekić, Cale Basaraba, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2462-2468
Open Access | Times Cited: 11
Lithium and the risk of severe COVID-19 infection: A retrospective population-based register study
Niklas Nilsson, Marie Bendix, Louise Öhlund, et al.
Journal of Psychosomatic Research (2025) Vol. 190, pp. 112053-112053
Open Access
Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period
Yeon Mi Hwang, Ryan Roper, Samantha N. Piekos, et al.
The Journal of Maternal-Fetal & Neonatal Medicine (2024) Vol. 37, Iss. 1
Open Access | Times Cited: 3
Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine
Eun‐Sook Park, Chan Young Shin, Se Jin Jeon, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 6, pp. 659-684
Closed Access | Times Cited: 3
Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19
David Kartchner, Kevin McCoy, Janhvi Dubey, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 6
Cortical GABA Levels Are Reduced in Post-Acute COVID-19 Syndrome
Ksenija Marinković, D. R. White, A. Myers, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1666-1666
Open Access | Times Cited: 6
Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
A Population-Based Cross-Sectional Investigation of COVID-19 Hospitalizations and Mortality Among Autistic People
Dewy Nijhof, Filip Sosenko, Daniel Mackay, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies
Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3005-3020
Closed Access | Times Cited: 2
The Effects of Antipsychotics and Selective Serotonin Reuptake Inhibitors on the Development of Long Covid in a Large Veteran Population
Jerry Bradley, Fei Tang, Dominique M. Tosi, et al.
(2024)
Closed Access
Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities
Ivan Papic, Petra Bistrović, Ivan Krečak, et al.
Pharmacology (2024), pp. 1-8
Closed Access
Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease
Zhenxiang Gao, Ian Dorney, Pamela B. Davis, et al.
Journal of Alzheimer s Disease (2024) Vol. 102, Iss. 1, pp. 99-109
Closed Access
References

Immune system (2024), pp. 471-578
Closed Access
Stress and Immunity
Hymie Anisman, Shawn Hayley, Alexander W. Kusnecov
Immune system (2024), pp. 163-196
Closed Access
COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brain
Siu Wa Tang, Daiga M. Helmeste, Brian E. Leonard
Acta Neuropsychiatrica (2023) Vol. 35, Iss. 5, pp. 248-269
Open Access | Times Cited: 1
Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
Udo Bonnet
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
STRESS AND HYPERTENSION IN WAR AND COVID-19 CONDITIONS
L. M. Samokhina, Iurii Rudyk
Fìzìologìčnij žurnal (2023) Vol. 69, Iss. 5, pp. 100-113
Open Access | Times Cited: 1
What did the COVID-19 epidemic learn psychiatrists?
В. Д. Менделевич, Foat F. Gatin, Rustem R. Khamitov
Neurology Bulletin (2022) Vol. LIV, Iss. 4, pp. 5-13
Open Access | Times Cited: 1
Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events
Yeon Mi Hwang, Ryan Roper, Samantha N. Piekos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Treatment and outcomes of 95 post-Covid patients with an antidepressant and neurobiological explanations
Carla C.P. Rus, Bert de Vries, Ingmar E. J. de Vries, et al.
Research Square (Research Square) (2023)
Open Access
Treatment of 95 post-Covid patients with SSRIs
Carla P. Rus, Bert E. K. de Vries, Ingmar E. J. de Vries, et al.
Research Square (Research Square) (2023)
Open Access
Clinical and pharmacological implications for a high rate of unrecognized SARS-CoV-2 infected psychiatric patients
Benedetta Vai, Mario Gennaro Mazza
Brain Behavior and Immunity (2023) Vol. 116, pp. 124-125
Closed Access
Page 1 - Next Page

Scroll to top